ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Ohio Center Helps Women Stop Smoking, Reduce Cervical Cancer Risk

October 29, 2004

Half of New NCI Funds in FY02 Spent on Grants

November 22, 2002

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

July 30, 2004

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

$1 Million Gift to Duke Funds Urologic Research Center.

November 24, 2000

Wyngaarden Law With Appointment Report; DeVita Tells Congress “We’re Addressing The Issue Internally”

March 20, 1987